Tyra Biosciences, Inc. (TYRA)
37.15
-1.03
(-2.70%)
USD |
NASDAQ |
Mar 20, 16:00
37.29
+0.14
(+0.38%)
After-Hours: 20:00
Tyra Biosciences Research and Development Expense (Quarterly) : 28.05M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 44.64M |
| Entrada Therapeutics, Inc. | 33.07M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Ionis Pharmaceuticals, Inc. | 279.36M |
| Agios Pharmaceuticals, Inc. | 86.79M |